More DCAT Value Chain Insights

In-depth analysis of the critical issues impacting the full spectrum of the pharmaceutical manufacturing value chain.

Will the trend of combining API and drug-product development and manufacturing services into a “one-stop shop” business model for CDMOs continue? DCAT Value Chain Insights examines recent deals and investments. Tracking activity among end-to-end...

A recent analysis by researchers at the Olin Business School at Washington University in St. Louis, Missouri, examines the US manufacturing base for active pharmaceutical ingredients (APIs) for essential medicines and the top 100 generic drugs....

Which modality, small molecules or biologics, leads among the top-selling products? A look at the top-selling products industry-wide and blockbusters from select leading bio/pharma companies provides the answer. Modality of top-selling...

The Congressional Budget Office (CBO) released a simulation model for analyzing the impact of US legislative drug pricing proposals on new drug development. The CBO projects that certain proposals, if adopted, may reduce the number of drugs...

The US and the EU are continuing to advance their assessment of their supply chains for regulatory starting materials, intermediates, and APIs for essential medicines. Where do those assessments now stand, and what will be the impact on global API...

Kevin Ali, the CEO of Organon, the new company formed from the spin-off of Merck & Co.’s women’s health, established brands, and biosimilars businesses, is leading the new, independent company that launched in June 2021. What’s the strategy and...

Drug delivery is important not only for ensuring bioavailability for therapeutic benefit but also for product differentiation and market success. DCAT Value Chain Insights highlights technology advances in drug delivery for injectable and...

Supply-chain resiliency and agility are characteristics of companies ranked with the top supply chains according to a recent analysis and ranking by The Gartner Group of the Top 25 supply chains in 2021. Four bio/pharma companies made the Top 25....